Market Research Logo

Jordan Pharmaceuticals and Healthcare Report Q4 2015

Jordan Pharmaceuticals and Healthcare Report Q4 2015

BMI View: The majority of Jordan's pharmaceuticals will remain sourced from abroad despite theimpressive domestic manufacturing industry. Local drugmakers will continue to supply the market withgeneric medicines but higher value innovative drugs will continue to be supplied by multinationals.Significant counterfeit medicine circulation and economic and political instability in neighbouring Syriawill weigh down the domestic pharmaceutical markets appeal to foreign investment.

Headline Expenditure Projections

Pharmaceuticals: JOD643mn (USD905mn) in 2014 to JOD683mn (USD962mn) in 2015; +6.3% inlocal currency terms and US dollar terms. Forecast unchanged from Q315.

Healthcare: JOD1.85bn (USD2.61bn) in 2014 to JOD1.97bn (USD2.77bn) in 2015; +6.2% in localcurrency terms and US dollar terms. Forecast in line with Q315.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Jordan 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019)
Prescription Drug Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Jordan
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Jordan 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Jordan 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Jordan 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Expenditure Breakdown
Table: GDP By Expenditure (Jordan 2012-2019)
Industry Risk/Reward Indicies
Middle East and Africa Risk/Reward Index - Q4 2015
Jordan Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Insurance
Table: Healthcare Resources (Jordan 2009-2014)
Table: Healthcare Personnel (Jordan 2009-2014)
Table: Healthcare Activity (Jordan 2009-2014)
Research and Development Sector
Clinical Trials
Regulatory Development
Regulatory Developments
Intellectual Property Regime
Pricing And Reimbursement Regime
Competitive Landscape
Pharmaceutical Industry
Domestic Pharmaceutical Sector
Foreign Pharmaceutical Sector
Pharmaceutical Wholesale Sector
Retail Pharmacy Sector
Company Profile
Dar al-Dawa
GlaxoSmithKline
Hikma Pharmaceuticals
Jordanian Pharmaceutical Manufacturing Company (JPM)
Merck & Co
Novartis
Pharma International Company
Pfizer
Sanofi
United Pharmaceutical Manufacturers
Demographic Forecast
Jordan Demographic Forecast
Table: Population Headline Indicators (Jordan 1990-2025)
Table: Key Population Ratios (Jordan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Jordan 1990-2025)
Table: Population By Age Group (Jordan 1990-2025)
Table: Population By Age Group % (Jordan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report